Page last updated: 2024-10-27

flecainide and Pulmonary Fibrosis

flecainide has been researched along with Pulmonary Fibrosis in 2 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akoun, GM1
Cadranel, JL1
Israel-Biet, D1
Gauthier-Rahman, S1
Hanston, P1
Evrard, P1
Mahieu, P1
Wallemacq, P1
Friob, M1
Hassoun, A1

Other Studies

2 other studies available for flecainide and Pulmonary Fibrosis

ArticleYear
Flecainide-associated pneumonitis.
    Lancet (London, England), 1991, Jan-05, Volume: 337, Issue:8732

    Topics: Flecainide; Humans; Infant, Newborn; Male; Middle Aged; Pulmonary Fibrosis; Respiratory Function Tes

1991
Flecainide-associated interstitial pneumonitis.
    Lancet (London, England), 1991, Feb-09, Volume: 337, Issue:8737

    Topics: Acute Disease; Arrhythmias, Cardiac; Flecainide; Humans; Male; Middle Aged; Pulmonary Fibrosis; Resp

1991